Among the Sema4 genes, SEMA4B and SEMA4C showed mild expression increase in gliomas and glioblastoma subtypes, while the other Sema4s appeared mainly unchanged or downregulated (Fig. S1). The gene discussed is SEMA3F; the disease is central nervous system cancer.